U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C21H22O8
Molecular Weight 402.3946
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NOBILETIN

SMILES

COC1=CC=C(C=C1OC)C2=CC(=O)C3=C(O2)C(OC)=C(OC)C(OC)=C3OC

InChI

InChIKey=MRIAQLRQZPPODS-UHFFFAOYSA-N
InChI=1S/C21H22O8/c1-23-13-8-7-11(9-15(13)24-2)14-10-12(22)16-17(25-3)19(26-4)21(28-6)20(27-5)18(16)29-14/h7-10H,1-6H3

HIDE SMILES / InChI

Molecular Formula C21H22O8
Molecular Weight 402.3946
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 19:04:07 UTC 2023
Edited
by admin
on Sat Dec 16 19:04:07 UTC 2023
Record UNII
D65ILJ7WLY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NOBILETIN
INCI  
Official Name English
NSC-618903
Code English
4H-1-BENZOPYRAN-4-ONE, 2-(3,4-DIMETHOXYPHENYL)-5,6,7,8-TETRAMETHOXY-
Systematic Name English
FLAVONE, 3',4',5,6,7,8-HEXAMETHOXY-
Systematic Name English
NOBILETIN [USP-RS]
Common Name English
3',4',5,6,7,8-HEXAMETHOXYFLAVONE
Systematic Name English
NSC-76751
Code English
2-(3,4-DIMETHOXYPHENYL)-5,6,7,8-TETRAMETHOXY-4H-1-BENZOPYRAN-4-ONE
Systematic Name English
HEXAMETHOXYFLAVONE
WHO-DD  
Systematic Name English
NOBILETIN [INCI]
Common Name English
5,6,7,8,3',4'-HEXAMETHOXYFLAVONE
Systematic Name English
Hexamethoxyflavone [WHO-DD]
Common Name English
Classification Tree Code System Code
DSLD 4008 (Number of products:1)
Created by admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
Code System Code Type Description
WIKIPEDIA
NOBILETIN
Created by admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
PRIMARY
EPA CompTox
DTXSID30197275
Created by admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
PRIMARY
CHEBI
7602
Created by admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
PRIMARY
NSC
618903
Created by admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
PRIMARY
RS_ITEM_NUM
1467848
Created by admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
PRIMARY
FDA UNII
D65ILJ7WLY
Created by admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
PRIMARY
PUBCHEM
72344
Created by admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
PRIMARY
NSC
76751
Created by admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
PRIMARY
CAS
478-01-3
Created by admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
PRIMARY
SMS_ID
300000032958
Created by admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> CONSTITUENT ALWAYS PRESENT
44% Cell growth rate of mouse myeloid leukemia M1 cells at 50 uM of compound vs control
PARENT -> CONSTITUENT ALWAYS PRESENT
48% Cell growth rate of human acute promyelocytic leukemia HL-60 cells at 50 uM of compound vs control
TRANSPORTER -> INHIBITOR
Decreased the IC50 value of paclitaxel by 15.92-fold. Restored the sensitivity of paclitaxel, doxorubicin, docetaxel, and daunorubicin in ABCB1, overexpressing A2780/T and A549/T cells.
IC50